[Post-marketing surveillance information transmitted via electronic mail in a University Hospital].
M J
MJ
Jean-Pastor
M F
MF
Affaton
N
N
Prost
N
N
Nguyen
F
F
Rodor
D019380:Anti-HIV Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D020117:Cisapride / Q000009:adverse effects; D003195:Computer Communication Networks; D005602:France; D005765:Gastrointestinal Agents / Q000009:adverse effects; D006784:Hospitals, Teaching; D006801:Humans; D008942:Mitoxantrone / Q000009:adverse effects; D019829:Nevirapine / Q000009:adverse effects; D011358:Product Surveillance, Postmarketing
D019380:Anti-HIV Agents; D000970:Antineoplastic Agents; D005765:Gastrointestinal Agents; D019829:Nevirapine; D008942:Mitoxantrone; D020117:Cisapride